Shandong Liteng Biotechnology Co., Ltd., established in March 2014, is a high-tech fine chemical company integrating R&D, production and sales. The company's registered address is located in Jinan High-tech Zone, Shandong Province, with 2 R&D centers in Jinan, Shandong and Heze, Shandong, and pilot plant and production base in Tai'an, Shandong, which can meet the needs of customers in different quantities.
The company's main business includes technical services, customized synthesis, and pilot production, involving small-scale, pilot, and large-scale production of pharmaceutical intermediates, material intermediates, and various unconventional raw materials. The products involve customization and production of esters, hydrazides, phenylhydrazine hydrochloride, acetonitrile, brominated, iodated, heterocyclic pyridines, pyrazole carboxylic acids, and other related types of products.......
It has advanced synthesis and testing equipment and a professional R&D team. The R&D personnel
rich practical experience in the professional field of fluorine chemicals.
Jinan, [Date] – Shandong Liteng International Trade Co., Ltd. (hereinafter referred to as "Shandong Liteng") is emerging as a key player in the global chemical market, leveraging its integrated capabilities in technical services, custom synthesis, and large-scale production to expand its
On September 3, 2025, a military parade to mark the 80th anniversary of the victory in the Chinese People's War of Resistance against Japanese Aggression and the World Anti-Fascist War was grandly held at Tiananmen Square in Beijing. Jinan Liheng Biotechnology Co., Ltd. organized all its employees
2024 CW domestic exhibition programMarch 13-15, 2024 The 14th China International New Fertilizer Exhibition (FSHOW) National Convention and Exhibition Center (Shanghai)March 20-22, 2024 The 27th China International Food Additives and Ingredients Exhibition (FSHOW) National Convention and Exhibition
1.The development trend of pharmaceutical intermediates industryThe development of fine chemicals is one of the solid foundations of China's construction of a manufacturing power, but also to achieve the national energy saving and emission reduction targets, the development of a low-carbon economy
Oral version of simelglutide approved for marketing in China, clinical results show that it can effectively lower sugar and lose weight.On January 26, 2024, the official website of the State Drug Administration (SDA) showed that Simeglutide tablets developed by Novo Nordisk were approved for